bamlanivimab anti-COVID drug, patient

Bamlanivimab, a medicine preventing a severe course of COVID-19 was given to the first patient in Masaryk Memorial Cancer Institute (MMCI) in Brno, Czech Republic, Friday, March 5, 2021. (CTK Photo/Vaclav Salek)

• Product Code
• ILEA000276949

• Registered date
• 2021/3/05 00:00:00

• Credit
• CTK / Kyodo News Images

• Media source
• CTK

• Media size
• 4928 × 3280 pixel

• Resolution
• 300 dpi

• Deployment size
• 3.52(MB)*

• Special instruction
• SLOVAKIA OUT, CZECH REPUBLIC OUT
  **The text may be generated by an automatic translation system**

*File size when opened in Photoshop, etc.